We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Equity Crowdfunding Pitches

Showing results
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go: Extended investment: £295,000
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go: Extended investment: Withheld
Stroli – the shopping trolley reimagined for modern needs. The shopping trolley, often associated with a particular image, is an untapped category ready for innovation. The market is flooded with generic, budget-friendly options that lack charm, with the exception of Rolser, which is pricier and claims the green niche. Stroli steps in as the go-to brand, offering a unique approach, positioning, voice, and eco-friendly credentials. Say goodbye to sore hands and plastic bags – Stroli makes shopping a pleasure with its high-quality, stylish trolley bags designed to enhance your convenience and style
days to go: Extended investment: Withheld
Yolk, also known as In One Basket Limited, is a pioneering company revolutionizing the food and coffee experience for people on the move. They provide high-quality sandwiches, salads, and improved breakfast options without the premium cost, boasting five successful locations in London and three upcoming openings in the second half of 2023
days to go: TBC investment: Withheld
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go: TBC investment: £127,001
Award-winning non-dairy luxury ice cream, which is also organic and vegan. Coconuts Naturally will be launching their range of 5 flavours in over 600 supermarkets across the UK from March 2019. after successfully achieving listings with Ocado, Morrison’s and Asda. The company differentiates itself from competitors by primarily using coconut cream and unrefined coconut sugar in their products. Coconuts Naturally have won seven Great Taste Awards and Peter Jones of Dragon's Den has claimed it the best free-from ice cream he has tasted. The business is raising funds to increase brand awareness by entering international markets. Coconuts Naturally is stocked at 2 supermarkets in Dubai, as well as launching in Hong Kong soon and currently seeking product registration in Saudi Arabia. The company will be focusing on marketing campaigns via digital and in-store promotions. In addition, due to the upcoming supermarket launch, the business will also be increasing stock levels to meet consumer demand.
days to go: Expired investment: £422,580
CityMunch allows restaurants to catch potential customers through real time offer platforms. Allowing restaurants to attract customers specifically in the least busiest times of the day. CityMunch will use the funding to expand throughout the city.
days to go: Expired investment: £174,582
Rightangled is a healthcare technology company backed by NHS England & regulated by the Care Quality Commission (CQC). It began its journey as a platform that would enable the use of genetic information within the medical practice, in an accurate, streamlined, and affordable way. It gradually established itself as a healthcare provider for screening and diagnostic services. Its Heart DNA Test project, launched in 2017, is helping patients minimize their cardiac risks and enabling doctors to have a complete risk profile for their patients. The project was appreciated and received funding from NHS England. Its next project, Fitness DNA Test, tapped into the fitness and wellbeing markets. Recently, in the wake of the COVID-19 threat, the company has developed a home-based throat swab test to detect the viral infection, by testing viral load presented in its nucleic acid material within (RNA). For its efforts, Rightangled has been featured on CNN, Sky News, LBC radio, Sky News radio, and Newsweek. With the investment, the company aims to release a mobile application by the end of 2020, and develop an AI system to give instant tailored health, diet, and fitness advice to its users based on the data gathered from patient-doctor interactions and patient responses.

Pitch Rated

81%

Gold

rating powered by

CROWD RATING™

days to go: Expired investment: £522,689
An award-winning grooming brand for men offering natural male beauty products, with the aim of becoming a global market leader. Hawkins & Brimble's range consists of 19 products sold in major retailers such as Sainsbury's, Boots and Etos, as well as in 10 countries around the world. In the year-to-date, the business has achieved revenues of more than £1.3m and has seen a YoY sales increase of over 100%. The 2018 Lloyds Bank National Business Awards has shortlisted the CEO of Hawkins & Brimble, Stephen Shortt, for The Duke of York New Entrepreneur of the Year Award. The brand has been featured in numerous publications including GQ, The Guardian and Shortlist Magazine. Hawkins & Brimble is currently sold in Norway, The Netherlands, China, South Africa and many other countries. The brand has registered its trademark in the EU, USA, and China. The company has recently signed a contract to sell their products in India and are currently in discussions with Brazil and Germany to launch their range in 2018/19.
days to go: Expired investment: £136,520
Brands reunited are looking to disrupt the modern craft beer market. Their sales are over £400k and are growing 100% year on year. They have two brands that are already in Watneys and Home Ales. The funding will be spent on building their brand and the team. 
days to go: Expired investment: £255,000
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph